The number of people with susceptibility test result for rifampicin in Germany
Germany: The number of people with susceptibility test result for rifampicin was 1,440 in 2021. ▲ Rising
Latest (2021)
1,440
Change on year
down 8.0%
World rank
58th
of 155 countries
All-time high
2,064
in 2018
All-time low
67
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Germany, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Germany stood at 1,440.
That represents a change of down 8.0% on the previous year and up 2,049.2% over five years.
Germany ranks 58th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Germany, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 67 | — |
| 2018 | 2,064 | +2980.6% |
| 2019 | 1,763 | -14.6% |
| 2020 | 1,565 | -11.2% |
| 2021 | 1,440 | -8.0% |
Germany compared with similar countries
- Germany's 1,440 is above the median for high income countries, which is 142, 10.1× the median. (61 countries reporting)
- Germany's 1,440 is above the median for Europe & Central Asia, which is 229.5, 6.3× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,298 | 67 | 2,064 | 3 |
| 2020s | 1,502 | 1,440 | 1,565 | 2 |
Countries ranked near Germany
More health data for Germany
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9955 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,164 deaths per 1,000 people (2090)
- Number of infants who die before age 1 368 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2000)
- Population ages 00-04, female, annual growth rate -2.18 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0216 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Germany?
- The number of people with susceptibility test result for rifampicin in Germany was 1,440 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Germany?
- The highest recorded value was 2,064 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Germany?
- The lowest recorded value was 67 in 2017.
- How does Germany rank for the number of people with susceptibility test result for rifampicin?
- Germany ranks 58th out of 155 countries with data for 2021.
- Where does this Germany data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).